Diagnos, Inc.

  • Market Cap: N/A
  • Industry: Computers - Software & Consulting
  • ISIN: CA2524423068
CAD
0.33
-0.03 (-9.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Diagnos, Inc. stock-summary
stock-summary
Diagnos, Inc.
Computers - Software & Consulting
DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.
Company Coordinates stock-summary
Company Details
7005 Taschereau Blvd Suite 340 , BROSSARD QC : J4Z 1A7
stock-summary
Tel: 1 450 6788882
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.46%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Francois Cote
Chairman of the Board
Mr. Andre Larente
President, Director
Mr. Francis Bellido
Director
Mr. Georges Hebert
Director
Dr. Reid Maclellan
Director
Dr. Jean-Francois Yale
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

CAD 35 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.78

stock-summary
Return on Equity

476.33%

stock-summary
Price to Book

-34.87